Implantation of an Endovascular Prosthesis for the Treatment of Abdominal Aortic Aneurysms: Use of a Machine Learning Model From CT Images to Predict Complications

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Observational
SUMMARY

Abdominal aortic aneurysm, a condition characterised by an increase in the diameter of the aorta, can be treated either surgically or endovascularly. In the latter, an endoprosthesis consisting of a metal spring covered with an impermeable fabric is inserted through an artery and deployed inside the aorta. This new method appears to be less invasive than surgery, but its long-term results are not yet fully understood. As a result, patients who have undergone this treatment are monitored by their surgeon to ensure that there is no endoleak. Several research teams have proposed analysing medical images to predict this risk of endoleak. Doctors are now trying to use artificial intelligence to automate the analysis of these images.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Treated for an abdominal aortic aneurysm through endovascular prosthesis implantation

Locations
Other Locations
France
Groupe Hospitalier de la Rochelle Ré Aunis
RECRUITING
La Rochelle
Contact Information
Primary
Caroline Allix-Béguec, Ph.D.
caroline.allix-beguec@ght-atlantique17.fr
+33516494246
Time Frame
Start Date: 2025-04-14
Estimated Completion Date: 2026-06-30
Participants
Target number of participants: 300
Treatments
Patient treated for an abdominal aortic aneurysm
Indications for infrarenal abdominal aortic aneurysm (AAA) treatment with abdominal aortic endoprosthesis (AAE) were :~* AAAs with greatest diameter \> 50 mm for women and \> 55 mm for men, or diameter increase of more than 5 mm in six months and 10 mm in 1 year.~* A symptomatic or complicated AAA is treated regardless of size.~* Despite the absence of conclusive data, a saccular AAA is considered high-risk due to its particular morphology and is proposed for treatment even if its greatest diameter is \< 50 mm.
Sponsors
Collaborators: La Rochelle University
Leads: Groupe Hospitalier de la Rochelle Ré Aunis

This content was sourced from clinicaltrials.gov